GlassScriptPhysician profile
Dmitri Petrychenko
NPI 1588644272
$3,201.49
in general payments reported to CMS, 2019-2025
24 companies · $423 in 2025
The $423 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $316 · 2020: $394 · 2021: $609 · 2022: $504 · 2023: $559 · 2024: $397 · 2025: $423.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,378.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,378.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $490.52 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $452.64 | 2022-2025 | Relistor |
| Forte Bio-Pharma LLC | $360.38 | 2021-2023 | Prolate, Nalocet |
| Horizon Therapeutics Plc | $357.81 | 2020-2022 | |
| Scilex Pharmaceuticals INC. | $343.26 | 2021-2025 | Ztlido |
| Valinor Pharma, LLC | $216.36 | 2023-2025 | Movantik |
| Redhill Biopharma INC. | $180.47 | 2021-2022 | |
| Daiichi Sankyo INC. | $174.96 | 2019 | |
| Boston Scientific Corporation | $78.87 | 2023 | Wavewriter Alpha Prime 16 |
| Abbvie INC. | $72.86 | 2025 | |
| Pfizer INC. | $70.66 | 2020-2021 | |
| Biohaven Pharmaceuticals, INC. | $59.93 | 2021 | |
| Vertos Medical, INC. | $59.52 | 2023 | Mild Device Kit |
| Medtronic USA, INC. | $49.40 | 2019 | |
| Pacira Therapeutics, INC. | $40.52 | 2020-2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $28.97 | 2025 | Rexulti |
| Globus Medical, INC. | $26.71 | 2025 | Senza |
| Lilly USA, LLC | $22.02 | 2022 | |
| Protega Pharmaceutials INC | $21.94 | 2024 | Roxybond |
| Ibsa Pharma INC. | $21.10 | 2025 | Licart, Flector, Tirosint |
| Medtronic, INC. | $20.00 | 2021 | |
| Grt US Holding, INC. | $18.96 | 2022 | |
| Shionogi INC | $17.73 | 2019 | |
| Medline Industries LP | $15.90 | 2024 | Medline Industries, INC., Medline |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dmitri Petrychenko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.